Cargando…

Cross-reactive immune responses to monkeypox virus induced by MVA vaccination in mice

Mpox (monkeypox) infection cases increased recently in non-Mpox outbreak areas, potentially causing an international threat. The desire to defend against a potential outbreak has led to renewed efforts to develop Mpox vaccines. In this report, mice were immunized with various doses of modified vacci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Feixia, He, Cheng, Liu, Min, Yuan, Ping, Tian, Shihua, Zheng, Mei, Zhang, Linya, Zhou, Xu, Xu, Fangjingwei, Luo, Jian, Li, Xiuling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278293/ https://www.ncbi.nlm.nih.gov/pubmed/37337226 http://dx.doi.org/10.1186/s12985-023-02085-0

Ejemplares similares

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals
por: Zaeck, Luca M., et al.
Publicado: (2022)

A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice
por: Weger-Lucarelli, James, et al.
Publicado: (2014)

DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge
por: Nigam, Pragati, et al.
Publicado: (2007)

Vaccinia-Virus-Based Vaccines Are Expected to Elicit Highly Cross-Reactive Immunity to the 2022 Monkeypox Virus
por: Ahmed, Syed Faraz, et al.
Publicado: (2022)

Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines
por: Meseda, Clement A., et al.
Publicado: (2016)

Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo
por: Priyamvada, Lalita, et al.
Publicado: (2022)

AddaVax-Adjuvanted H5N8 Inactivated Vaccine Induces Robust Humoral Immune Response against Different Clades of H5 Viruses
por: Gao, Feixia, et al.
Publicado: (2022)

Immunization of mice with vaccinia virus Tiantan strain yields antibodies cross-reactive with protective antigens of monkeypox virus
por: Yang, Lei, et al.
Publicado: (2022)

Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2
por: Jabbar, Tamara Kusay, et al.
Publicado: (2013)

Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022
por: Berens-Riha, Nicole, et al.
Publicado: (2022)

Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice
por: Kalodimou, Georgia, et al.
Publicado: (2023)

Monkeypox virus: past and present
por: Dou, Ya-Mei, et al.
Publicado: (2022)

The Future of Smallpox Vaccination: is MVA the key?
por: Slifka, Mark K
Publicado: (2005)

DNA/MVA Vaccines for HIV/AIDS
por: Iyer, Smita S., et al.
Publicado: (2014)

Asymptomatic Mpox Virus Infection in Subjects Presenting for MVA-BN Vaccine
por: Matusali, Giulia, et al.
Publicado: (2023)

The land-scape of immune response to monkeypox virus
por: Li, Heng, et al.
Publicado: (2022)

Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

Mechanisms of immune evasion of monkeypox virus
por: Zandi, Milad, et al.
Publicado: (2023)

Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination
por: Raccagni, Angelo Roberto, et al.
Publicado: (2022)

Monkeypox virus vaccine evolution and global preparedness for vaccination
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations
por: Palgen, Jean-Louis, et al.
Publicado: (2020)

mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge
por: Hou, Fujun, et al.
Publicado: (2023)

Poxviruses and the immune system: Implications for monkeypox virus
por: Saghazadeh, Amene, et al.
Publicado: (2022)

P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
por: Robinson, HL, et al.
Publicado: (2009)

Newborn Mice Vaccination with BCG.HIVA(222) + MVA.HIVA Enhances HIV-1-Specific Immune Responses: Influence of Age and Immunization Routes
por: Saubi, Narcís, et al.
Publicado: (2011)

Monkeypox virus: A new etiology for reactive lymphocytes in peripheral blood
por: Neeley, Jared, et al.
Publicado: (2022)

A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants
por: Gao, Feixia, et al.
Publicado: (2023)

The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses
por: Pérez, Patricia, et al.
Publicado: (2021)

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine
por: Shen, Xiaoying, et al.
Publicado: (2017)

Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus
por: Sang, Ye, et al.
Publicado: (2023)

The monkeypox virus
por: Halani, Sheliza, et al.
Publicado: (2022)

Comparison of Monkeypox Viruses Pathogenesis in Mice by In Vivo Imaging
por: Osorio, Jorge E., et al.
Publicado: (2009)

Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2012)

A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates
por: Leung-Theung-Long, Stéphane, et al.
Publicado: (2015)

Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice
por: Langenmayer, Martin C., et al.
Publicado: (2023)

The evolving epidemiology of monkeypox virus
por: Li, Heng, et al.
Publicado: (2022)

The 90 MVA transformer
Publicado: (1974)

Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigens
por: Fang, Zhenhao, et al.
Publicado: (2023)

Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals
por: Otter, Ashley D., et al.
Publicado: (2023)

Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses
por: Rollier, Christine S., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_24ggkrr53r6odumk9ui7eq2fk9